DUBLIN–(BUSINESS WIRE)–The “Acne Medication Market by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2019-2027” report has been added to ResearchAndMarkets.com’s offering.
The global acne medication market was valued at $11,865.9 million in 2019, and is projected to reach $13,357. 57 million by 2027 at a CAGR of 3. 80% from 2020 to 2027.
Acne is a common skin disorder that is mainly caused by excessive production of sebum. In this disorder, there is an outbreak of lesions, which are known as pimples. Acne usually begins at puberty and the condition may worsen during adolescence. It can be treated by acne medications depending upon severity.
Acne treatment includes reduction of sebum production, removal of dead skin cells, and killing of bacteria with the help of oral medications and drugs. Acne medications are either applied directly, which are present in formulations or taken in the form of oral pills. These medications work by reducing inflammation and oil production. They also fight with bacteria finally preventing scarring. Common acne medications include retinoids, antibiotics, isotretinoin, and benzoyl peroxide.
Growth of the global acne medication market is driven by the rise in prevalence of acne diseases, which is the major factor that contributes toward growth of the acne medication market. (Read more…) Moreover, other factors that fuel the market growth include unhealthy urban lifestyle and presence of robust acne medications in pipeline.
However, side-effects associated with the use of acne medications and presence of alternative treatment impede the market growth. Conversely, development of effective medications with lesser side effects and high market potential in untapped emerging economies are expected to provide lucrative growth opportunities for the market growth.
KEY MARKET PLAYERS
- Almirall SA.
- Bausch Health Companies Inc.
- GlaxoSmithKline Plc (GSK)
- Johnson & Johnson
- Galderma S. A
- Mayne Pharma Group Limited
- Mylan N. V.
- Pfizer Inc.
- Sun Pharmaceutical Industries Limited
- Teva Pharmaceutical Industries Ltd.
Key Topics Covered:
Chapter 1: Introduction
Chapter 2: Executive Summary
Chapter 3: Market Overview
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Top Player Positioning, 2019
3.4. Market Dynamics
3.4.1. Drivers
3.4.1.1. Increase in Prevalence of Acne Diseases
3.4.1.2. Unhealthy Urban Lifestyle
3.4.1.3. The Rise in Focus on Skin Care Products
3.4.2. Restraints
3.4.2.1. Side Effects Associated With Acne Medications
3.4.2.2. Presence of Alternatives for Acne Treatment
3.4.3. Opportunities
3.4.3.1. Opportunities in Emerging Economies
3.4.3.2. Development of Therapeutics With Lesser Side Effects
3.4.4. Impact Analyses
3.5. Clinical Trials
3.6. Patent Analysis (2011-2020)
3.6.1. Patent Analysis, by Year
3.7. Impact of Covid-19 on Acne Medication Market
Chapter 4: Acne Medication Market, by Therapeutic Class
4.1. Overview
4.1.1. Market Size and Forecast
4.2. Retinoid
4.2.1. Key Market Trends, Growth Factors, and Opportunities
4.2.2. Market Size and Forecast, by Type
4.2.2.1. Topical & Combination Retinoids
4.2.2.1.1. Market Size and Forecast, by Region
4.2.2.2. Oral Retinoid (Isotretinoin)
4.2.2.2.1. Market Size and Forecast, by Region
4.2.3. Market Size and Forecast, by Region
4.2.4. Market Analysis, by Country
4.3. Antibiotics
4.3.1. Key Market Trends, Growth Factors, and Opportunities
4.3.2. Market Size and Forecast, by Type
4.3.2.1. Topical & Combination Antibiotics
4.3.2.1.1. Market Size and Forecast, by Region
4.3.2.2. Oral Antibiotics
4.3.2.2.1. Market Size and Forecast, by Region
4.3.3. Market Size and Forecast, by Region
4.3.4. Market Analysis, by Country
4.4. Salicylic Acid
4.4.1. Key Market Trends, Growth Factors, and Opportunities
4.4.2. Market Size and Forecast, by Region
4.4.3. Market Analysis, by Country
4.5. Benzoyl Peroxide
4.6. Other Medications
Chapter 5: Acne Medication Market, by Formulation
5.1. Overview
5.1.1. Market Size and Forecast
5.2. Topical Medications
5.2.1. Market Size and Forecast, by Region
5.2.2. Market Analysis, by Country
5.3. Oral Medications
Chapter 6: Acne Medication Market, by Type
6.1. Overview
6.1.1. Market Size and Forecast
6.2. Prescription Medicines
6.3. Over-The-Counter Medicines
Chapter 7: Acne Medication Market, by Acne Type
7.1. Overview
7.1.1. Market Size and Forecast
7.2. Non-Inflammatory Acne
7.3. Inflammatory Acne
Chapter 8: Acne Medication Market, by Distribution Channel
8.1. Overview
8.1.1. Market Size and Forecast
8.2. Retail Store
8.2.1. Market Size and Forecast, by Region
8.2.2. Market Analysis, by Country
8.3. Pharmacy & Drug Store
8.4. E-Commerce
Chapter 9: Acne Medication Market, by Region
Chapter 10: Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/5a9bbg
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900